Investors

Catalent, Inc. is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs more than 8,700 people, including over 1,000 scientists, at 31 facilities across five continents and in fiscal 2015 generated more than $1.8 billion in annual revenue.

NYSE: CTLT

Price
Change
Today's Open
Previous Close
Percent Change
New York Stock Exchange

Investor Contact

Investor Relations Dept
Catalent, Inc.
14 Schoolhouse Road
Somerset, NJ 08873

Phone +1 732 537 6325
Fax +1 732 537 5932
investors@catalent.com

development
With our broad range of expert services, we drive faster, more efficient development timelines and produce better products.
delivery
We are a world leader in drug delivery solutions with a proven track record of helping our customers create better treatments.
supply
As a seamless extension of your supply chain, we offer global integrated manufacturing and packaging solutions.